Outset Medical PE Ratio 2019-2025 | OM

Current and historical p/e ratio for Outset Medical (OM) from 2019 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Outset Medical PE ratio as of May 29, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Outset Medical PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-29 17.61 0.00
2025-03-31 11.06 $-29.15 0.00
2024-12-31 16.65 $-37.18 0.00
2024-09-30 10.16 $-41.38 0.00
2024-06-30 57.75 $-47.08 0.00
2024-03-31 33.30 $-50.67 0.00
2023-12-31 81.15 $-52.47 0.00
2023-09-30 163.20 $-53.82 0.00
2023-06-30 328.05 $-52.62 0.00
2023-03-31 276.00 $-52.92 0.00
2022-12-31 387.30 $-51.13 0.00
2022-09-30 238.95 $-51.27 0.00
2022-06-30 222.90 $-48.28 0.00
2022-03-31 681.00 $-44.38 0.00
2021-12-31 691.35 $-43.18 0.00
2021-09-30 741.60 $-41.38 0.00
2021-06-30 749.70 $-83.21 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.346B $0.114B
Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.151B 48.75
Hims & Hers Health (HIMS) United States $11.939B 124.05
Tempus AI (TEM) United States $9.210B 0.00
IRhythm Technologies (IRTC) United States $4.513B 0.00
Inspire Medical Systems (INSP) United States $4.137B 64.64
Privia Health (PRVA) United States $2.813B 192.25
Enovis (ENOV) United States $1.861B 10.37
Clover Health Investments (CLOV) United States $1.593B 0.00
Schrodinger (SDGR) United States $1.579B 0.00
Phreesia (PHR) United States $1.385B 0.00
Omnicell (OMCL) United States $1.376B 24.27
Azenta (AZTA) United States $1.241B 57.66
10x Genomics (TXG) United States $1.091B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Fulgent Genetics (FLGT) United States $0.626B 0.00
Talkspace (TALK) United States $0.495B 148.00
Veradigm (MDRX) United States $0.460B 0.00
Claritev (CTEV) United States $0.438B 0.00
Standard BioTools (LAB) United States $0.414B 0.00
TruBridge (TBRG) United States $0.358B 793.33
Nyxoah SA (NYXH) Belgium $0.267B 0.00
Health Catalyst (HCAT) United States $0.256B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.135B 0.00
EUDA Health Holdings (EUDA) Singapore $0.132B 0.00
Pulmonx (LUNG) United States $0.119B 0.00
American Well (AMWL) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.087B 3.31
111 (YI) China $0.068B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00